Workflow
太力科技
icon
Search documents
太力科技(301595) - 首次公开发行股票并在创业板上市之上市公告书提示性公告
2025-05-15 21:01
广东太力科技集团股份有限公司 首次公开发行股票并在创业板上市 之上市公告书提示性公告 保荐人(主承销商):民生证券股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 经深圳证券交易所审核同意,广东太力科技集团股份有限公司(以下简称"太 力科技"、"本公司"、"发行人")发行的人民币普通股股票将于 2025 年 5 月 19 日在深圳证券交易所创业板上市,上市公告书全文和首次公开发行股票并在 创业板上市招股说明书全文披露于中国证券监督管理委员会指定信息披露网站: 巨潮资讯网(www.cninfo.com.cn);中证网(www.cs.com.cn);中国证券网 (www.cnstock.com);证券时报网(www.stcn.com);证券日报网(www.zqrb.cn); 经济参考网(www.jjckb.cn);中国金融新闻网(www.financialnews.com.cn); 中国日报网(www.chinadaily.com.cn),供投资者查阅。 一、上市概况 | | | 日收 T-4 | 年扣 2024 | 年 2024 扣非后 | 对应的静 ...
太力科技(301595) - 北京德恒律师事务所关于公司首次公开发行股票并在创业板上市的法律意见书
2025-05-15 21:01
法律意见 关于广东太力科技集团股份有限公司 首次公开发行股票并在深圳证券交易所创业板上市的 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 北京德恒律师事务所 致:广东太力科技集团股份有限公司 | 一、本次发行上市的批准和授权 3 | | --- | | 二、发行人本次发行上市的主体资格 4 | | 三、发行人本次发行上市的实质条件 5 | | 四、本次发行上市保荐人和保荐代表人 6 | | 五、发行人及相关责任主体出具的承诺及约束措施 7 | | 六、结论意见 7 | 关于广东太力科技集团股份有限公司 北京德恒律师事务所 首次公开发行股票并在深圳证券交易所创业板上市的法律意见 北京德恒律师事务所 关于广东太力科技集团股份有限公司 首次公开发行股票并在深圳证券交易所创业板上市的 法律意见 德恒 01F20201334-64 号 根据广东太力科技集团股份有限公司(以下简称"发行人""公司")与本所签订 的《专项法律顾问服务协议》,本所接受发行人的委托,担任发行人申请首次公开发行 股票并在深圳证券交易所创业板上市(以下简称 ...
太力科技(301595) - 首次公开发行股票并在创业板上市之上市公告书
2025-05-15 21:01
股票简称:太力科技 股票代码:301595 广东太力科技集团股份有限公司 Guangdong Taili Technology Group Co.,Ltd. (中山市石岐区湖滨北路 40 号之二前座) 首次公开发行股票并在创业板上市 之上市公告书 保荐人(主承销商) (中国(上海)自由贸易试验区浦明路 8 号) 二零二五年五月 广东太力科技集团股份有限公司 上市公告书 特别提示 广东太力科技集团股份有限公司(以下简称"太力科技"、"本公司"、"公 司"或"发行人")股票将于 2025 年 5 月 19 日在深圳证券交易所(以下简称 "深交所")创业板上市。 (一)"本公司及全体董事、监事、高级管理人员保证上市公告书的真实性、 准确性、完整性,承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏, 并依法承担法律责任"; (二)"深圳证券交易所、有关政府机关对本公司股票上市及有关事项的意 见,均不表明对本公司的任何保证"; 创业板公司具有业绩不稳定、经营风险高、退市风险大等特点,投资者面临 较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露的风 险因素,审慎做出投资决定。 本公司提醒投资者应充分 ...
太力科技: 北京德恒律师事务所关于公司首次公开发行股票并在创业板上市的法律意见书
Zheng Quan Zhi Xing· 2025-05-15 13:33
Core Viewpoint - Guangdong Taili Technology Group Co., Ltd. is preparing for its initial public offering (IPO) and listing on the Shenzhen Stock Exchange's Growth Enterprise Market, with legal opinions provided by Beijing Deheng Law Firm confirming compliance with relevant laws and regulations [1][2][11]. Group 1: Approval and Authorization - On October 28, 2022, the company held a shareholder meeting that approved the proposal for the IPO and authorized the board to handle related matters [4]. - On August 11, 2023, the Shenzhen Stock Exchange's Listing Review Committee confirmed that the company meets the issuance and listing conditions [5]. - On February 18, 2025, the China Securities Regulatory Commission approved the company's IPO registration, valid for 12 months from the date of approval [5]. Group 2: Company Qualifications - The company was established on May 11, 2021, as a joint-stock company, having been transformed from a limited liability company that was founded on April 24, 2003, thus meeting the requirement of three years of continuous operation [6]. - The company is legally established and in good standing, with no circumstances that would require termination under relevant laws and regulations [6]. Group 3: Substantial Conditions for Listing - The company has obtained necessary approvals from internal authorities and regulatory bodies, confirming compliance with the relevant laws and regulations for the IPO [10]. - The total share capital before the IPO is 81.21 million yuan, and after the IPO, it will increase to 108.28 million yuan, meeting the minimum capital requirements [7]. - The company plans to publicly issue 27.07 million A-shares, which will constitute over 25% of the total shares post-issuance [8]. Group 4: Sponsorship and Commitments - Minsheng Securities has been appointed as the sponsor for the IPO, fulfilling the qualifications required by the relevant regulations [10]. - The company and its key stakeholders have made public commitments regarding the IPO, including measures for accountability in case of non-compliance [11]. Group 5: Conclusion - The legal opinion concludes that the company has obtained all necessary approvals for the IPO, possesses the qualifications for listing, and has complied with all relevant legal and regulatory requirements [11].
又一家居生活生产商要上市了!自爆曾刷单、好评返现,66元检验真改了吗?
Core Viewpoint - Tai Li Technology, a company preparing for an IPO, has revealed its past practices of manipulating sales through fake orders and incentivizing positive reviews, raising concerns about its business ethics and compliance [1][3][4]. Group 1: Company Background - Tai Li Technology is positioned as a leader in vacuum packaging and biological preservation, serving major global retailers like IKEA, Costco, and Walmart [1]. - The company produces various household products, including seamless hooks, vacuum storage bags, preservation bags, and garbage bags [2]. Group 2: Controversial Practices - The company's prospectus disclosed that from 2019 to 2020, it engaged in practices of fake orders amounting to 398,000 yuan and 895,500 yuan respectively [3]. - In 2021, the company also reported 45,100 yuan in "cashback for positive reviews" and "cashback for photo sharing," which could equate to nearly 10,000 orders if calculated at 5 yuan per order [4]. - These practices ceased in 2022, coinciding with the company's IPO preparation and compliance guidance from Minsheng Securities [5][6]. Group 3: Compliance and Verification - Following the cessation of these practices, a verification was conducted by purchasing products from the company on major e-commerce platforms, which showed no evidence of the previous manipulative practices [7][8]. Group 4: Industry Perspective - The issue of fake orders and incentivized reviews reflects broader industry challenges, where businesses feel pressured by platform algorithms that prioritize sales and ratings, leading to unethical practices [9]. - This situation results in a detrimental cycle where honest businesses are pushed out, and consumers are misled by false reviews, illustrating the concept of "bad money driving out good" [9].
太力科技冲刺“家居收纳第一股” 实控人“一股独大”格局下频现内控问题
Xin Lang Zheng Quan· 2025-05-12 08:44
Core Viewpoint - Tai Li Technology Group is on the verge of going public, having reported significant revenue and profit growth from 2022 to 2024, but faces concerns regarding financial governance and potential performance volatility post-IPO [1][2]. Financial Performance - Revenue for Tai Li Technology from 2022 to 2024 is projected to be 637.85 million, 835.27 million, and 1.01962 billion respectively, with net profits of 58.87 million, 84.98 million, and 87.66 million, indicating consistent growth [1]. - The company transitioned from long-term losses prior to 2019, where it had accumulated losses of 120 million, to profitability starting in 2019 [1]. Ownership Structure - The ownership structure of Tai Li Technology shows a dominant control by the actual controller, Shi Zhengbing, who holds 82.31% of the voting rights through direct shares and employee stock ownership plans [2]. Financial Governance Issues - The company has faced multiple financial internal control issues, including frequent employee embezzlement cases and significant financial oversight failures, such as a loss of 1.63 million in Shanghai from 2012 to 2015 due to employee misconduct [3]. - There are allegations of improper financial practices, including fund borrowing from the actual controller and using personal accounts for company transactions [3]. - The company admitted to engaging in fraudulent online sales practices amounting to 1.29 million from 2019 to 2020, raising concerns about the authenticity of its financial performance [3].
资金流向周报丨东方财富、新易盛、胜宏科技上周获融资资金买入排名前三
一、证券市场回顾 南财金融终端数据显示,上周(5月6日-5月9日,下同),上证综指周内上涨1.92%,收于3342.0点,最高3359.73点;深证成指周内上涨2.29%,收于10126.83 点,最高10248.98点;创业板指周内上涨3.27%,收于2011.77点,最高2036.1点。在全球市场中,主要指数有涨有跌。纳斯达克综指下跌0.27%,道琼斯工业 指数下跌0.16%,标普500下跌0.47%。亚太地区,恒生指数上涨1.61%,日经225指数上涨1.83%。 二、新股申购情况 上周有3只新股发行,详情见下表: | 股票代码 | 股票简称 | 申购日期 | | --- | --- | --- | | 301595.SZ | 太力科技 | 20250508 | | 603014.SH | 威高血净 | 20250508 | | 688755.SH | 汉邦科技 | 20250507 | 三、融资融券情况 上周共有16条开始执行回购公告,其中执行金额最多的5条公告为: | 证券代码 | 证券简称 | | --- | --- | | 601877 | 正泰电器 | | 002145 | 中核钛白 | | ...
新股二级交投表现趋于向好,但量变到质变或仍待观察确认
Huajin Securities· 2025-05-12 02:25
Group 1: New Stock Market Performance - The average increase of new stocks listed since 2024 is approximately 3.0%, with about 82.9% of new stocks showing positive returns[1] - The average increase for new stocks on the North Exchange is 5.5%, with around 96.2% of new stocks experiencing gains[5] - The average issuance price-to-earnings ratio for new stocks last week was 24.2X, with a subscription success rate of 0.0267%[4] Group 2: Market Trends and Recommendations - The current market is in a transformation window, with significant policy clarity expected to gradually materialize, indicating a potential new active cycle[2] - Caution is advised due to ongoing external disturbances, including geopolitical tensions and tariff negotiations, which may lead to market fluctuations[2] - Focus should be on near-term new stocks that have undergone sufficient adjustment and offer relatively high cost-performance ratios, particularly those benefiting from hot themes or policy expectations[3] Group 3: Upcoming New Stocks - This week, five new stocks are set to complete subscriptions, including one from the Sci-Tech Innovation Board and two from the Growth Enterprise Market[7] - One stock, Guqi Down Material, is expected to start pricing inquiries, being a significant supplier of duck down and goose down materials[8]
IPO要闻汇 | 健信超导冲刺科创板,天工股份下周登陆北交所
Cai Jing Wang· 2025-05-09 10:34
IPO Review and Registration Progress - Ningbo Jianxin Superconducting Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, marking the third new acceptance this year [2] - The company reported revenues of 359 million yuan, 451 million yuan, and 425 million yuan for 2022 to 2024, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan respectively [2] - The company plans to raise 865 million yuan through its IPO for projects including the production of superconducting magnets and working capital [3] - Lianchuan Biotechnology has also received acceptance for its IPO on the Beijing Stock Exchange, aiming to raise 300 million yuan for projects related to gene technology and working capital [4] - The company reported revenues of 234 million yuan, 287 million yuan, and 367 million yuan from 2022 to 2024, with net profits of 52.76 million yuan, 53.49 million yuan, and 60.06 million yuan respectively [4] - Dana Biotechnology submitted its IPO registration on the Beijing Stock Exchange, focusing on early rapid diagnostic technology for invasive fungal diseases [6] - Han Gao Group's IPO registration has been approved, with projected revenues of 2.857 billion yuan and net profits of 531 million yuan for 2024 [6] New Stock Subscription and Listing Dynamics - Three new stocks are scheduled for subscription this week, including Hanbang Technology, Weigao Blood Purification, and Taili Technology [8] - Hanbang Technology aims to raise 598 million yuan for the production of liquid chromatography equipment, with projected revenues of 691 million yuan and net profits of 79 million yuan for 2024 [8] - Weigao Blood Purification plans to raise 1.351 billion yuan for smart production and other projects, with sales expenses exceeding 600 million yuan from 2022 to 2024 [9] - Taili Technology focuses on new materials and plans to raise 542 million yuan for production and logistics center construction, with projected revenues of 1.02 billion yuan and net profits of 88 million yuan for 2024 [9] Upcoming Listings - Tian Gong Co., Ltd. is set to be listed on the Beijing Stock Exchange on May 13, with projected revenues of 383 million yuan, 1.035 billion yuan, and 801 million yuan from 2022 to 2024 [11] - The company plans to raise 360 million yuan for the construction of high-end titanium and titanium alloy production lines [11] Policy and Regulatory Trends - The China Securities Regulatory Commission (CSRC) plans to introduce policies to deepen reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market, enhancing the system's inclusiveness and adaptability [12]
公司研究室IPO周报:绿茶集团预计5月16日香港上市
Sou Hu Cai Jing· 2025-05-09 06:34
IPO Dynamics - No companies are scheduled for IPO meetings in the A-share market [1] - No new stocks are listed this week in the A-share market [2] New Stock Subscription - Three new stocks are available for subscription this week, with no new stock subscriptions scheduled for next week [3] - Hanbang Technology (688755) is set to be subscribed on May 7, while Taili Technology (301595) and Weigao Blood Purification (603014) will be subscribed on May 8 [3] Hong Kong Stock Market - Several companies have passed the hearing for listing on the Hong Kong Stock Exchange, including Heng Rui Pharmaceutical, CATL, and Ji Hong Technology [4] - On May 8, Hong Kong's stock market welcomed the listing of "Hushang Ayi," which raised approximately HKD 195 million by issuing 241,130 shares at HKD 113.12 per share [5] - The founders of Hushang Ayi have a combined net worth of USD 1.1 billion, holding approximately 78.78% of the company's shares post-IPO [5] Upcoming Listings - Green Tea Group is expected to list on May 16, with a share price of HKD 7.19 and a total of 168 million shares being offered [6][7] - The company has secured eight cornerstone investors, with a total investment of approximately USD 87.33 million [7] Company Developments - Xiaopeng Motors is considering an IPO for its flying car subsidiary, Xiaopeng Huitian, with potential listings in Hong Kong or the U.S. [8] - Xiaopeng Huitian has received a significant loan of CNY 1.26 billion from a consortium of banks to support its manufacturing base [8] Regulatory Updates - The Hong Kong Stock Exchange has launched a "Tech Company Fast Track" to facilitate the listing of specialized technology and biotech companies, allowing for confidential submission of applications [9] - This initiative aims to support early-stage companies in understanding listing rules and preparing for the IPO process [9]